Pharmolife Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 03-12-2024
- Paid Up Capital ₹ 50.00 K
as on 03-12-2024
- Company Age 11 Months 14 Days
- Last Filing with ROC 31 Mar 2024
About Pharmolife Biotechnologies
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Mohamed Nayaz and Parveez Ahmed serve as directors at the Company.
- CIN/LLPIN
U13996KA2024PTC184665
- Company No.
184665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2024
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmolife Biotechnologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Nayaz  | Director | 11-Feb-2024 | Current |
| Parveez Ahmed | Director | 11-Feb-2024 | Current |
Financial Performance of Pharmolife Biotechnologies.
Enhance accessibility to Pharmolife Biotechnologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmolife Biotechnologies?
Unlock access to Pharmolife Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Primecare Pharma Private LimitedActive 6 years 10 monthsMohamed Nayaz and Parveez Ahmed are mutual person
Primecare Trading & Consulting LlpActive 4 years 2 monthsMohamed Nayaz and Parveez Ahmed are mutual person
- Primecare Medical Services And Multispeciality Clinics (India) Private LimitedActive 12 years 2 months
Mohamed Nayaz and Parveez Ahmed are mutual person
- Primecare Enterprises Private LimitedActive 6 years 11 months
Mohamed Nayaz and Parveez Ahmed are mutual person
Gloaid Pharma Private LimitedActive 9 months 2 daysMohamed Nayaz and Parveez Ahmed are mutual person
- Coreshelters Infra Private LimitedActive 11 months 25 days
Mohamed Nayaz and Parveez Ahmed are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmolife Biotechnologies?
Pharmolife Biotechnologies has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmolife Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmolife Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.